Chemical Compound

ENVIOMYCIN

CAS Registry Number 33103-22-9
ENVIOMYCIN chemical structure
Primary Record

ENVIOMYCIN

In stock
7,096 g
Purity
99.3 %
CAS
33103-22-9

Compound Identifiers & Properties

CAS
33103-22-9
PubChem CID
135565326
SMILES
C1CNC(=N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CO)CO)NC(=O)C[C@H]([C@@H](CCN)O)N)N
Canonical SMILES
NCC[C@@H](O)[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H]([C@H]2CCNC(N)=N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O

Names & Synonyms

  • ENVIOMYCIN
  • Enviomycine
  • Tuberactinomycin N
  • Enviomycinum
  • Enviomicina
  • Enviomycina
  • Enviomycin [INN]
  • Tuberactinomycin-N
  • Enviomycine [INN-French]
  • Enviomycinum [INN-Latin]
  • ENVIOMYCIN [MI]
  • Enviomycina [INN-Spanish]
  • RefChem:137062
  • UNII-XU299C23A2
  • ENVIOMYCIN [MART.]
  • ENVIOMYCIN [WHO-DD]
  • XU299C23A2
  • TUBERACTINOMYCIN N [MI]
  • CHEMBL2146142
  • J04AB06
  • DB08993
  • C25-H43-N13-O10
  • 33103-22-9
  • tereoisomer of ((15-(3,6-diamino-4-hydroxyhexanamido)-3-(hexahydro-2-imino-4-pyrimidinyl)-9,12-bis(hydroxymethyl-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadec-6-ylidene)methyl)urea
  • Viomycin, 1-((3R,4R)-4-hydroxy-3,6-diaminohexanoic acid)-6-(L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine)-, (R)-
  • ((15-(3,6-DIAMINO-4-HYDROXYHEXANAMIDO)-3-(HEXAHYDRO-2-IMINO-4-PYRIMIDINYL)-9,12-BIS(HYDROXYMETHYL-2,5,8,11,14-PENTAOXO-1,4,7,10,13-PENTAAZACYCLOHEXADEC-6-YLIDENE)METHYL)UREA
  • (3R,4R)-3,6-diamino-N-((3S,6Z,9S,12S,15S)-3-((4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl)-6-((carbamoylamino)methylidene)-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl)-4-hydroxyhexanamide
  • (3R,4R)-3,6-diamino-N-((3S,6Z,9S,12S,15S)-3-((4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-6-((carbamoylamino)methylidene)-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl)-4-hydroxyhexanamide
  • 3,6-diamino-N-[(6E)-3-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
  • 3,6-diamino-N-[(6Z)-3-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
  • Tuberactinomycin N; stereoisomer of ((15-(3,6-diamino-4-hydroxyhexanamido)-3-(hexahydro-2-imino-4-pyrimidinyl)-9,12-bis(hydroxymethyl-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadec-6-ylidene)methyl)urea
  • Viomycin, 1-(threo-4-hydroxy-L-3,6-diaminohexanoic acid)-6-(L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine)-, (R)-
  • Viomycin, 1-(threo-4-hydroxy-L-3,6-diaminohexanoic acid)-6-[L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine]-, (R)-